Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral misoprostol versus intramuscular oxytocin for active management of the third stage of labour
PACTR202211835951582Phase 4Completed
- Sponsor
- Dr. Sambo Atanda Abdulrasaq
- Start
- Oct 2017
- Modality
- Recombinant Proteins and Enzymes, Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in postpartum hemorrhage (PPH) comparing Oxytocin group with Misoprostol group (2 arms). Primary endpoints: Blood loss after delivery and Proportion of participants with postpartum hemorrhage. Started Oct 2017; status: completed.
02
Drugs
misoprostoloxytocin
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on PACTR202211835951582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202211835951582.